Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SMALL-MOLECULE INHIBITOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 52 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Miller, MD; Hazuda, DJ
      New antiretroviral agents: looking beyond protease and reverse transcriptase

      CURRENT OPINION IN MICROBIOLOGY
    2. Salisbury, JL
      The contribution of epigenetic changes to abnormal centrosomes and genomicinstability in breast cancer

      JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
    3. Tamamura, H; Omagari, A; Hiramatsu, K; Kanamoto, T; Gotoh, K; Kanbara, K; Yamamoto, N; Nakashima, H; Otaka, A; Fujii, N
      Synthesis and evaluation of bifunctional anti-HIV agents based on specificCXCR4 antagonists-AZT conjugation

      BIOORGANIC & MEDICINAL CHEMISTRY
    4. Tamamura, H; Sugioka, M; Odagaki, Y; Omagari, A; Kan, Y; Oishi, S; Nakashima, H; Yamamoto, N; Peiper, SC; Hamanaka, N; Otaka, A; Fujii, N
      Conformational study of a highly specific CXCR4 inhibitor, T140, disclosing the close proximity of its intrinsic pharmacophores associated with strong anti-HIV activity

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    5. Tamamura, H; Omagari, A; Hiramatsu, K; Gotoh, K; Kanamoto, T; Xu, YN; Kodama, E; Matsuoka, M; Hattori, T; Yamamoto, N; Nakashima, H; Otaka, A; Fujii, N
      Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    6. De Clercq, E
      New developments in anti-HIV chemotherapy

      CURRENT MEDICINAL CHEMISTRY
    7. Kanbara, K; Sato, S; Tanuma, J; Tamamura, H; Gotoh, K; Yoshimori, M; Kanamoto, T; Kitano, M; Fujii, N; Nakashima, H
      Biological and genetic characterization of a human immunodeficiency virus strain resistant to CXCR4 antagonist t134

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    8. Doranz, BJ; Filion, LG; Diaz-Mitoma, F; Sitar, DS; Sahai, J; Baribaud, FD; Orsini, MJ; Benovic, JL; Cameron, W; Doms, RW
      Safe use of the CXCR4 inhibitor ALX40-4C in humans

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    9. LaBranche, CC; Galasso, G; Moore, JP; Bolognesi, DP; Hirsch, MS; Hammer, SM
      HIV fusion and its inhibition

      ANTIVIRAL RESEARCH
    10. Spenlehauer, C; Gordon, CA; Trkola, A; Moore, JP
      A luciferase-reporter gene-expressing T-cell line facilitates neutralization and drug-sensitivity assays that use either R5 or X4 strains of human immunodeficiency virus type 1

      VIROLOGY
    11. De Clercq, E
      New developments in anti-HIV chemotherapy

      PURE AND APPLIED CHEMISTRY
    12. Baribaud, F; Edwards, TG; Sharron, M; Brelot, T; Heveker, N; Price, K; Mortari, F; Alizon, M; Tsang, M; Doms, RW
      Antigenically distinct conformations of CXCR4

      JOURNAL OF VIROLOGY
    13. Dragic, T
      An overview of the determinants of CCR5 and CXCR4 co-receptor function

      JOURNAL OF GENERAL VIROLOGY
    14. Kapoor, TM; Mitchison, TJ
      Eg5 is static in bipolar spindles relative to tubulin: evidence for a static spindle matrix

      JOURNAL OF CELL BIOLOGY
    15. Turner, J; Anderson, R; Guo, J; Beraud, C; Fletterick, R; Sakowicz, R
      Crystal structure of the mitotic spindle kinesin Eg5 reveals a novel conformation of the neck-linker

      JOURNAL OF BIOLOGICAL CHEMISTRY
    16. Govaerts, C; Blanpain, C; Deupi, X; Ballet, S; Ballesteros, JA; Wodak, SJ; Vassart, G; Pardo, L; Parmentier, M
      The TXP motif in the second transmembrane helix of CCR5 - A structural determinant of chemokine-induced activation

      JOURNAL OF BIOLOGICAL CHEMISTRY
    17. Clapham, PR; McKnight, A
      HIV-1 receptors and cell tropism

      BRITISH MEDICAL BULLETIN
    18. Hogan, CM; Hammer, SM
      Host determinants in HIV infection and disease - Part 2: Genetic factors and implications for antiretroviral therapeutics

      ANNALS OF INTERNAL MEDICINE
    19. Moore, JP; Stevenson, M
      New targets for inhibitors of HIV-1 replication

      NATURE REVIEWS MOLECULAR CELL BIOLOGY
    20. Rusconi, S; Merill, DP; Catamancio, SL; Citterio, P; Bulgheroni, E; Croce, F; Chou, TC; Yang, OO; Herrmann, SH; Galli, M; Hirsch, MS
      In vitro inhibition of HIV-1 by Met-SDF-1 beta alone or in combination with antiretroviral drugs

      ANTIVIRAL THERAPY
    21. Blair, WS; Lin, PF; Meanwell, NA; Wallace, OB
      HIV-1 entry - an expanding portal for drug discovery

      DRUG DISCOVERY TODAY
    22. De Clercq, E
      Novel compounds in preclinical/early clinical development for the treatment of HIV infections

      REVIEWS IN MEDICAL VIROLOGY
    23. Tamamura, H; Omagari, A; Oishi, S; Kanamoto, T; Yamamoto, N; Peiper, SC; Nakashima, H; Otaka, A; Fujii, N
      Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads todevelopment of effective anti-HIV agents with very high selectivity indexes

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    24. Murakami, T; Yamamoto, N
      Roles of chemokines and chemokine receptors in HIV-1 infection

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    25. Cabrera, C; Gutierrez, A; Blanco, J; Barretina, J; Litovchick, A; Lapidot, A; Evdokimov, AG; Clotet, B; Este, JA
      Anti-human immunodeficiency virus activity of novel aminoglycoside-arginine conjugates at early stages of infection

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    26. Lapidot, A; Litovchick, A
      Novel HIV Tat antagonists

      DRUG DEVELOPMENT RESEARCH
    27. D'Souza, MP; Cairns, JS; Plaeger, SF
      Current evidence and future directions for targeting HIV entry - Therapeutic and prophylactic strategies

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    28. Blanco, J; Barretina, J; Henson, G; Bridger, G; De Clercq, E; Clotet, B; Este, JA
      The CXCR4 antagonist AMD3100 efficiently inhibits cell-surface-expressed human immunodeficiency virus type 1 envelope-induced apoptosis

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    29. Cihlar, T; Bischofberger, N
      Recent developments in antiretroviral therapies

      ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35
    30. Doms, RW
      Beyond receptor expression: The influence of receptor conformation, density, and affinity in HIV-1 infection

      VIROLOGY
    31. De Clercq, E
      Inhibition of HIV infection by bicyclams, highly potent and specific CXCR4antagonists

      MOLECULAR PHARMACOLOGY
    32. Daelemans, D; Schols, D; Witvrouw, M; Pannecouque, C; Hatse, S; van Dooren, S; Hamy, F; Klimkait, T; De Clercq, E; Vandamme, AM
      A second target for the peptoid Tat/transactivation response element inhibitor CGP64222: Inhibition of human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry

      MOLECULAR PHARMACOLOGY
    33. Rusconi, S; Catamancio, SL; Citterio, P; Bulgheroni, E; Croce, F; Herrmann, SH; Offord, RE; Galli, M; Hirsch, MS
      Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: In vitro studies of mixed virus infections

      JOURNAL OF VIROLOGY
    34. Sei, S; Yang, QE; O'Neill, D; Yoshimura, K; Nagashima, K; Mitsuya, H
      Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain

      JOURNAL OF VIROLOGY
    35. Wallace, O
      No entry for HIV

      CHEMISTRY IN BRITAIN
    36. Zhang, J; Lautar, S; Huang, S; Ramsey, C; Cheung, A; Li, JH
      GPI 6150 prevents H2O2 cytotoxicity by inhibiting poly(ADP-ribose) polymerase

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    37. Takamune, N; Misumi, S; Shoji, S
      Cyclic zinc-dithiocarbamate-S,S '-dioxide blocks CXCR4-mediated HIV-1 infection

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    38. Rowland-Jones, S
      The role of chemokine receptors in HIV infection

      SEXUALLY TRANSMITTED INFECTIONS
    39. de Clercq, E
      Inhibition of HIV infection by bicyclams, highly potent and specific CXCR4antagonists

      EUROPEAN CYTOKINE NETWORK
    40. Owais, M; Arya, SK
      Antiviral chemokines: Intracellular life of recombinant C-C chemokine RANTES

      JOURNAL OF HUMAN VIROLOGY
    41. Wells, TNC; Proudfoot, AEI
      Chemokine receptors and their antagonists in allergic lung disease

      INFLAMMATION RESEARCH
    42. Clapham, PR; Reeves, JD; Simmons, G; Dejucq, N; Hibbitts, S; McKnight, A
      HIV coreceptors, cell tropism and inhibition by chemokine receptor ligands

      MOLECULAR MEMBRANE BIOLOGY
    43. Willett, BJ; Hosie, MJ
      The role of the chemokine receptor CXCR4 in infection with feline immunodeficiency virus

      MOLECULAR MEMBRANE BIOLOGY
    44. Cammack, N
      Human immunodeficiency virus type 1 entry and chemokine receptors: a new therapeutic target

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    45. Derdeyn, CA; Costello, C; Kilby, JM; Sfakianos, G; Saag, MS; Kaslow, R; Bucy, RP
      Correlation between circulating stromal cell-derived factor 1 levels and CD4(+) cell count in human immunodeficiency virus type 1-infected individuals

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    46. Lee, B; Montaner, LJ
      Chemokine immunobiology in HIV-1 pathogenesis

      JOURNAL OF LEUKOCYTE BIOLOGY
    47. Gallo, RC; Garzino-Demo, A; DeVico, AL
      HIV infection and pathogenesis: What about chemokines?

      JOURNAL OF CLINICAL IMMUNOLOGY
    48. Miller, RJ; Meucci, O
      AIDS and the brain: is there a chemokine connection?

      TRENDS IN NEUROSCIENCES
    49. Ross, TM; Bieniasz, PD; Cullen, BR
      Role of chemokine receptors in HIV-1 infection and pathogenesis

      ADVANCES IN VIRUS RESEARCH, VOL 52
    50. Kawabata, T; Ujikawa, M; Egawa, T; Kawamoto, H; Tachibana, K; Iizasa, H; Katsura, Y; Kishimoto, T; Nagasawa, T
      A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    51. Trkola, A; Matthews, J; Gordon, C; Ketas, T; Moore, JP
      A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor

      JOURNAL OF VIROLOGY
    52. Romerio, F; Gallo, RC
      Novel biologic approaches for the treatment of AIDS

      JOURNAL OF LABORATORY AND CLINICAL MEDICINE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 04:15:30